The promises and challenges of human brain organoids as models of neuropsychiatric disease.
- Authors
- Quadrato, Giorgia; Brown, Juliana; Arlotta, Paola
- Year
- 2016
- Journal
- Nature medicine
- PMID
- 27783065
- DOI
- 10.1038/nm.4214
Neuropsychiatric disorders such as autism spectrum disorder (ASD), schizophrenia (SCZ) and bipolar disorder (BPD) are of great societal and medical importance, but the complexity of these diseases and the challenges of modeling the development and function of the human brain have made these disorders difficult to study experimentally. The recent development of 3D brain organoids derived from human pluripotent stem cells offers a promising approach for investigating the phenotypic underpinnings of these highly polygenic disorders and for understanding the contribution of individual risk variants and complex genetic background to human pathology. Here we discuss the advantages, limitations and future applications of human brain organoids as in vitro models of neuropsychiatric disease.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Advances in cellular and structural engineering of brain organoids for disease modeling: A Comprehensive Review. | Kim H et al. | β | 2026 | β |
| All-in-one generation and multiomic profiling of human whole brain organoid on a millifluidic plate. | Zhao W et al. | β | 2026 | β |
| Differentiation of human iPSCs into dopaminergic neurons: comparative analysis of 2D and 3D protocols for disease modeling and pharmacology. | Marcotto GS et al. | β | 2026 | β |
| Generating and characterizing human telencephalic brain organoids from stem cell-derived single neural rosettes. | Ullah HMA et al. | β | 2026 | β |
| Mapping the Cerebral Organoid Landscape: A Systematic Review of Preclinical 3D Models in Neuroscience. | Wolfram A et al. | β | 2026 | β |
| Neuronal Organoid Engineering and Disease-Focused High-Throughput Neuropharmacology: Advances, Limitations, and Translational Strategies. | Farasati Far B et al. | β | 2026 | β |
| Proteomic profiling of brain organoids and extracellular vesicles identifies early Alzheimer's disease biomarkers and drug response heterogeneity. | Boyd RJ et al. | β | 2026 | β |
| Why animal models are still needed for discoveries in mental health research. | Borgland S | β | 2026 | β |
| APOE4 impacts cortical neurodevelopment and alters network formation in human brain organoids. | Meyer-Acosta KK et al. | β | 2025 | β |
| Astrocyte-secreted cues promote neural maturation and augment activity in human forebrain organoids. | Zheng H et al. | β | 2025 | β |
| Brain Organoids and Assembloids-From Disease Modeling to Drug Discovery. | Ajongbolo AO et al. | β | 2025 | β |
| Bridging the gap in Parkinson's disease research: from general pathophysiology to advanced 3d cell culture models. | Keles B et al. | β | 2025 | β |
| Controlled-environment platform for electrophysiology recordings on organoids with Neuropixels 2.0. | Zhang Z et al. | β | 2025 | β |
| Cyborg organoids integrated with stretchable nanoelectronics can be functionally mapped during development. | Lin Z et al. | β | 2025 | β |
| Developing a feasible fast-track testing method for developmental neurotoxicity studies: alternative model for risk assessment of micro- and nanoplastics. | Wu X et al. | β | 2025 | β |
| Linking Mitochondrial Dysfunction, Neurotransmitter, and Neural Network Abnormalities and Mania: Elucidating Neurobiological Mechanisms of the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder. | Freyberg Z et al. | β | 2025 | β |
| Modeling neurodegenerative diseases with brain organoids: from development to disease applications. | Larriba-GonzΓ‘lez T et al. | β | 2025 | β |
| Model systems for emulating human tissue and physiology in psychiatric research. | Cheng K et al. | β | 2025 | β |
| Neural network tissue and myocytes co-culture system reveals effects of different myocytes on postnatal development of spinal cord neural network. | Yang S et al. | β | 2025 | β |
| Non-Invasive and Long-Term Electrophysiological Monitoring Sensors for Cerebral Organoids Differentiation. | Jin Y et al. | β | 2025 | β |
| Quantitative profiling of human brain organoid cell diversity across four protocols and multiple cell lines. | Naas J et al. | β | 2025 | β |
| Single-cell and spatial omics: exploring hypothalamic heterogeneity. | Junaid M et al. | β | 2025 | β |
| Single rosette-based generation of uniform cortical assembloids recapitulating cellular interactions between neurons and glial cells. | Kim E et al. | β | 2025 | β |
| Structural Analysis of Cerebral Organoids Using Confocal Microscopy and Transmission/Scanning Electron Microscopy. | Noh S et al. | β | 2025 | β |
| The Interface of Gene Editing with Regenerative Medicine. | Farag VE et al. | β | 2025 | β |
| Understanding monocyte-driven neuroinflammation in Alzheimer's disease using human cortical organoid microphysiological systems. | Tian C et al. | β | 2025 | β |
| Untangling the Molecular Mechanisms Contributing to Autism Spectrum Disorder Using Stem Cells. | Mattingly Z et al. | β | 2025 | β |
| Aging phenotype in AD brain organoids: Track to success and challenges. | Hossain MK et al. | β | 2024 | β |
| Application of an <i>in vitro</i> neuroinflammation model to evaluate the efficacy of magnesium-lithium alloys. | Bhat K et al. | β | 2024 | β |
| Chronic Opioid Treatment Arrests Neurodevelopment and Alters Synaptic Activity in Human Midbrain Organoids. | Kim HS et al. | β | 2024 | β |
| Comparing stem cells, transdifferentiation and brain organoids as tools for psychiatric research. | Bellon A | β | 2024 | β |
| Dynamic culture of cerebral organoids using a pillar/perfusion plate for the assessment of developmental neurotoxicity. | Acharya P et al. | β | 2024 | β |
| Human Brain In Vitro Model for Pathogen Infection-Related Neurodegeneration Study. | Yan Y et al. | β | 2024 | β |
| Human brain organoid: trends, evolution, and remaining challenges. | Li M et al. | β | 2024 | β |
| Human cerebral organoids: cellular composition and subcellular morphological features. | Mateos-MartΓnez P et al. | β | 2024 | β |
| Human induced pluripotent stem cell-derived planar neural organoids assembled on synthetic hydrogels. | Majumder J et al. | β | 2024 | β |
| Human-Induced Pluripotent Stem Cell (iPSC)-Derived GABAergic Neuron Differentiation in Bipolar Disorder. | Schill DJ et al. | β | 2024 | β |
| Limitations of human brain organoids to study neurodegenerative diseases: a manual to survive. | Urrestizala-Arenaza N et al. | β | 2024 | β |
| Microinstrumentation for Brain Organoids. | Patel D et al. | β | 2024 | β |
| Modeling common and rare genetic risk factors of neuropsychiatric disorders in human induced pluripotent stem cells. | Muhtaseb AW et al. | β | 2024 | β |
| Morphogenetic Designs, and Disease Models in Central Nervous System Organoids. | Bock M et al. | β | 2024 | β |
| Multiscale engineering of brain organoids for disease modeling. | Xu C et al. | β | 2024 | β |
| Pros and Cons of Human Brain Organoids to Study Alzheimer's Disease. | Sainz A et al. | β | 2024 | β |
| Regulation of cell fate by cell imprinting approach in vitro. | Hasannejad F et al. | β | 2024 | β |
| The Pattern of Copper Release in Copper-Based Nanoparticles Regulates Tumor Proliferation and Invasiveness in 3D Culture Models. | Garcia-Peiro JI et al. | β | 2024 | β |
| Therapeutic Transplantation of Human Central Nervous System Organoids for Neural Reconstruction. | Hong SJ et al. | β | 2024 | β |
| 344Laser bioprinting of human iPSC-derived neural stem cells and neurons: Effect on cell survival, multipotency, differentiation, and neuronal activity. | Koch L et al. | β | 2023 | β |
| Advancing preclinical models of psychiatric disorders with human brain organoid cultures. | Dixon TA et al. | β | 2023 | β |
| Application of colloidal photonic crystals in study of organoids. | Huang K et al. | β | 2023 | β |
| Biological and structural phenotypes associated with neurodevelopmental outcomes in congenital heart disease. | Verrall CE et al. | β | 2023 | β |
| Cell reprogramming for oligodendrocytes: A review of protocols and their applications to disease modeling and cell-based remyelination therapies. | McCaughey-Chapman A et al. | β | 2023 | β |
| Cross-Species Convergence of Brain Transcriptomic and Epigenomic Findings in Posttraumatic Stress Disorder: A Systematic Review. | NΓΊΓ±ez-Rios DL et al. | β | 2023 | β |
| Functional brain region-specific neural spheroids for modeling neurological diseases and therapeutics screening. | Strong CE et al. | β | 2023 | β |
| Functional genomics in stem cell models: considerations and applications. | Shevade K et al. | β | 2023 | β |
| Human 3D brain organoids: steering the demolecularization of brain and neurological diseases. | Adlakha YK | β | 2023 | β |
| Human microglial models to study host-virus interactions. | McMillan RE et al. | β | 2023 | β |
| Mapping the scientific output ofΒ organoids for modeling animal and human infectious diseases: A bibliometric assessment | Yan J et al. | β | 2023 | β |
| Multimodal charting of molecular and functional cell states via in situ electro-sequencing. | Li Q et al. | β | 2023 | β |
| Multi-omics data integration methods and their applications in psychiatric disorders. | Sathyanarayanan A et al. | β | 2023 | β |
| Oxytocin Receptor Expression in Hair Follicle Stem Cells: A Promising Model for Biological and Therapeutic Discovery in Neuropsychiatric Disorders. | Pandamooz S et al. | β | 2023 | β |
| Preclinical Testing Techniques: Paving the Way for New Oncology Screening Approaches. | van Rijt A et al. | β | 2023 | β |
| Revolutionizing Disease Modeling: The Emergence of Organoids in Cellular Systems. | Silva-Pedrosa R et al. | β | 2023 | β |
| The beneficial effects of chick embryo extract preconditioning on hair follicle stem cells: A promising strategy to generate Schwann cells. | Pandamooz S et al. | β | 2023 | β |
| Transition from Animal-Based to Human Induced Pluripotent Stem Cells (iPSCs)-Based Models of Neurodevelopmental Disorders: Opportunities and Challenges. | Guerreiro S et al. | β | 2023 | β |
| Unlocking Neural Function with 3D In Vitro Models: A Technical Review of Self-Assembled, Guided, and Bioprinted Brain Organoids and Their Applications in the Study of Neurodevelopmental and Neurodegenerative Disorders. | D'Antoni C et al. | β | 2023 | β |
| Using Human-Induced Pluripotent Stem Cell Derived Neurons on Microelectrode Arrays to Model Neurological Disease: A Review. | Lv S et al. | β | 2023 | β |
| Using Stems to Bear Fruit: Deciphering the Role of Alzheimer's Disease Risk Loci in Human-Induced Pluripotent Stem Cell-Derived Microglia. | Wickstead ES | β | 2023 | β |
| 3D Neural Network Composed of Neurospheroid and Bionanohybrid on Microelectrode Array to Realize the Spatial Input Signal Recognition in Neurospheroid. | Yoon J et al. | β | 2022 | β |
| Advanced inΒ vitro models: Microglia in action. | Cakir B et al. | β | 2022 | β |
| A nomenclature consensus for nervous system organoids and assembloids. | PaΘca SP et al. | β | 2022 | β |
| Building in vitro models of the brain to understand the role of <i>APOE</i> in Alzheimer's disease. | Pinals RL et al. | β | 2022 | β |
| Cell-line dependency in cerebral organoid induction: cautionary observations in Alzheimer's disease patient-derived induced pluripotent stem cells. | Lee JH et al. | β | 2022 | β |
| Engineering multicellular living systems-a Keystone Symposia report. | Cable J et al. | β | 2022 | β |
| Folding brains: from development to disease modeling. | Del-Valle-Anton L et al. | β | 2022 | β |
| Human iPSC-derived cerebral organoids model features of Leigh syndrome and reveal abnormal corticogenesis. | Romero-Morales AI et al. | β | 2022 | β |
| Imaging three-dimensional brain organoid architecture from meso- to nanoscale across development. | Rodriguez-Gatica JE et al. | β | 2022 | β |
| Knowledge graphs of ethical concerns of cerebral organoids. | Ding L et al. | β | 2022 | β |
| Longitudinal morphological and functional characterization of human heart organoids using optical coherence tomography. | Ming Y et al. | β | 2022 | β |
| Modeling Schizophrenia In Vitro: Challenges and Insights on Studying Brain Cells. | BrandΓ£o-Teles C et al. | β | 2022 | β |
| Modeling the Human Brain With <i>ex vivo</i> Slices and <i>in vitro</i> Organoids for Translational Neuroscience. | Nogueira GO et al. | β | 2022 | β |
| Production of human spinal-cord organoids recapitulating neural-tube morphogenesis. | Lee JH et al. | β | 2022 | β |
| Proteomic signatures of schizophrenia-sourced iPSC-derived neural cells and brain organoids are similar to patients' postmortem brains. | Nascimento JM et al. | β | 2022 | β |
| Reaching into the toolbox: Stem cell models to study neuropsychiatric disorders. | Whiteley JT et al. | β | 2022 | β |
| Spatial analysis of drug absorption, distribution, metabolism, and toxicology using mass spectrometry imaging. | Spruill ML et al. | β | 2022 | β |
| Teleost Fish and Organoids: Alternative Windows Into the Development of Healthy and Diseased Brains. | Fasano G et al. | β | 2022 | β |
| Three-Dimensional Cell Culture Systems in Pediatric and Adult Brain Tumor Precision Medicine. | Riedel NC et al. | β | 2022 | β |
| A novel integrated system using patient-derived glioma cerebral organoids and xenografts for disease modeling and drug screening. | Zhang L et al. | β | 2021 | β |
| Applications of brain organoids in neurodevelopment and neurological diseases. | Sun N et al. | β | 2021 | β |
| Bioelectrical interfaces with cortical spheroids in three-dimensions. | Kalmykov A et al. | β | 2021 | β |
| Brain Organoids: Filling the Need for a Human Model of Neurological Disorder. | Jalink P et al. | β | 2021 | β |
| Cortical spheroids display oscillatory network dynamics. | Sevetson JL et al. | β | 2021 | β |
| Devices and techniques used to obtain and analyze three-dimensional cell cultures. | Agrawal G et al. | β | 2021 | β |
| Extracellular vesicles from organoids and 3D culture systems. | Abdollahi S | β | 2021 | β |
| Generation of 2.5D lung bud organoids from human induced pluripotent stem cells. | Xu X et al. | β | 2021 | β |
| Human Brain Surrogates Research: The Onrushing Ethical Dilemma. | Greely HT | β | 2021 | β |
| Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery. | Qian L et al. | β | 2021 | β |
| Human sensorimotor organoids derived from healthy and amyotrophic lateral sclerosis stem cells form neuromuscular junctions. | Pereira JD et al. | β | 2021 | β |
| Mind the translational gap: using iPS cell models to bridge from genetic discoveries to perturbed pathways and therapeutic targets. | Pintacuda G et al. | β | 2021 | β |
| Modeling SARS-CoV-2 infection in individuals with opioid use disorder with brain organoids. | Willner MJ et al. | β | 2021 | β |
| Neuronal Differentiation from Induced Pluripotent Stem Cell-Derived Neurospheres by the Application of Oxidized Alginate-Gelatin-Laminin Hydrogels. | Distler T et al. | β | 2021 | β |
| Novel <i>in vitro</i> Experimental Approaches to Study Myelination and Remyelination in the Central Nervous System. | Marangon D et al. | β | 2021 | β |
| Optimization of cerebral organoids: a more qualified model for Alzheimer's disease research. | Bi FC et al. | β | 2021 | β |
| Production of Phenotypically Uniform Human Cerebral Organoids from Pluripotent Stem Cells. | Sivitilli A et al. | β | 2021 | β |
| Rapid and Efficient Generation of Myelinating Human Oligodendrocytes in Organoids. | Shaker MR et al. | β | 2021 | β |
| Screening Platforms for Genetic Epilepsies-Zebrafish, iPSC-Derived Neurons, and Organoids. | Shcheglovitov A et al. | β | 2021 | β |
| Stem cell-based models and therapies: a key approach into schizophrenia treatment. | Larijani B et al. | β | 2021 | β |
| Taming human brain organoids one cell at a time. | Atamian A et al. | β | 2021 | β |
| The Use of Stem Cell-Derived Organoids in Disease Modeling: An Update. | Azar J et al. | β | 2021 | β |
| Unraveling Human Brain Development and Evolution Using Organoid Models. | Fernandes S et al. | β | 2021 | β |
| WWOX-Related Neurodevelopmental Disorders: Models and Future Perspectives. | Steinberg DJ et al. | β | 2021 | β |
| 3D Brain Organoids: Studying Brain Development and Disease Outside the Embryo. | Velasco S et al. | β | 2020 | β |
| A Long-Living Bioengineered Neural Tissue Platform to Study Neurodegeneration. | Rouleau N et al. | β | 2020 | β |
| An FDA/CDER perspective on nonclinical testing strategies: Classical toxicology approaches and new approach methodologies (NAMs). | Avila AM et al. | β | 2020 | β |
| Biomaterials and Culture Systems for Development of Organoid and Organ-on-a-Chip Models. | D'Costa K et al. | β | 2020 | β |
| Brain Organoids: A Promising Living Biobank Resource for Neuroscience Research. | Li S et al. | β | 2020 | β |
| Breeding brains? Patients' and laymen's perspectives on cerebral organoids. | Haselager DR et al. | β | 2020 | β |
| CNS organoids: an innovative tool for neurological disease modeling and drug neurotoxicity screening. | Chhibber T et al. | β | 2020 | β |
| CRISPRi-based radiation modifier screen identifies long non-coding RNA therapeutic targets in glioma. | Liu SJ et al. | β | 2020 | β |
| Developing a Multidisciplinary Approach for Engineering Stem Cell Organoids. | Wechsler ME et al. | β | 2020 | β |
| Electrophysiological Analysis of Brain Organoids: Current Approaches and Advancements. | Passaro AP et al. | β | 2020 | β |
| Genetic and environmental factors of schizophrenia and autism spectrum disorder: insights from twin studies. | Imamura A et al. | β | 2020 | β |
| Hallmarks of NLRP3 inflammasome activation are observed in organotypic hippocampal slice culture. | Hoyle C et al. | β | 2020 | β |
| How can preclinical cognitive research further neuropsychiatric drug discovery? Chances and challenges. | GyertyΓ‘n I | β | 2020 | β |
| In vitro modeling for inherited neurological diseases using induced pluripotent stem cells: from 2D to organoid. | Nam KH et al. | β | 2020 | β |
| iPSC modeling of rare pediatric disorders. | Freel BA et al. | β | 2020 | β |
| Mental health dished up-the use of iPSC models in neuropsychiatric research. | McNeill RV et al. | β | 2020 | β |
| Microtechnology-based methods for organoid models. | Velasco V et al. | β | 2020 | β |
| Modeling cell-autonomous motor neuron phenotypes in ALS using iPSCs. | Hawrot J et al. | β | 2020 | β |
| Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques. | Collo G et al. | β | 2020 | β |
| Probing disrupted neurodevelopment in autism using human stem cell-derived neurons and organoids: An outlook into future diagnostics and drug development. | Yang G et al. | β | 2020 | β |
| Reality check for organoids in neuroscience. | Marx V | β | 2020 | β |
| Recent progress in translational engineered in vitro models of the central nervous system. | Nikolakopoulou P et al. | β | 2020 | β |
| Remote nongenetic optical modulation of neuronal activity using fuzzy graphene. | Rastogi SK et al. | β | 2020 | β |
| Review of Artificial Intelligence Applications and Algorithms for Brain Organoid Research. | Badai J et al. | β | 2020 | β |
| Robust production of uniform human cerebral organoids from pluripotent stem cells. | Sivitilli AA et al. | β | 2020 | β |
| Schizophrenia and Influenza at the Centenary of the 1918-1919 Spanish Influenza Pandemic: Mechanisms of Psychosis Risk. | KΔpiΕska AP et al. | β | 2020 | β |
| Shifting Developmental Trajectories During Critical Periods of Brain Formation. | Dehorter N et al. | β | 2020 | β |
| Suppression of hypersynchronous network activity in cultured cortical neurons using an ultrasoft silicone scaffold. | Sumi T et al. | β | 2020 | β |
| Surface-Functionalized Self-Standing Microdevices Exhibit Predictive Localization and Seamless Integration in 3D Neural Spheroids. | Lecomte A et al. | β | 2020 | β |
| The abiding relevance of mouse models of rare mutations to psychiatric neuroscience and therapeutics. | Gogos JA et al. | β | 2020 | β |
| Top ten discoveries of the year: Neurodevelopmental disorders. | Dierssen M | β | 2020 | β |
| Total Recall: Lateral Habenula and Psychedelics in the Study of Depression and Comorbid Brain Disorders. | Vitkauskas M et al. | β | 2020 | β |
| Translating insights from neuropsychiatric genetics and genomics for precision psychiatry. | Rees E et al. | β | 2020 | β |
| Upgrading the Physiological Relevance of Human Brain Organoids. | Del Dosso A et al. | β | 2020 | β |
| All Together Now: Modeling the Interaction of Neural With Non-neural Systems Using Organoid Models. | Chukwurah E et al. | β | 2019 | β |
| Basic and translational aging research in China: present and future. | He X et al. | β | 2019 | β |
| Brain Organoids-A Bottom-Up Approach for Studying Human Neurodevelopment. | Karzbrun E et al. | β | 2019 | β |
| Cell diversity in the human cerebral cortex: from the embryo to brain organoids. | Arlotta P et al. | β | 2019 | β |
| Central and Peripheral Changes in FOS Expression in Schizophrenia Based on Genome-Wide Gene Expression. | Huang J et al. | β | 2019 | β |
| Compartmentalized Devices as Tools for Investigation of Human Brain Network Dynamics. | Fantuzzo JA et al. | β | 2019 | β |
| Drug discovery in psychopharmacology: from 2D models to cerebral organoidsβ©. | Rossetti AC et al. | β | 2019 | β |
| Engineering Microfluidic Organoid-on-a-Chip Platforms. | Yu F et al. | β | 2019 | β |
| Engineering of human brain organoids with a functional vascular-like system. | Cakir B et al. | β | 2019 | β |
| From enhanceropathies to the epigenetic manifold underlying human cognition. | Vitriolo A et al. | β | 2019 | β |
| Functional maturation of human neural stem cells in a 3D bioengineered brain model enriched with fetal brain-derived matrix. | Sood D et al. | β | 2019 | β |
| Genetic Modification of Brain Organoids. | Fischer J et al. | β | 2019 | β |
| Glioblastoma's Next Top Model: Novel Culture Systems for Brain Cancer Radiotherapy Research. | Caragher S et al. | β | 2019 | β |
| Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 2: Spheroids, Organoids, and Disease Modeling. | Eglen RM et al. | β | 2019 | β |
| Individual brain organoids reproducibly form cell diversity of the human cerebral cortex. | Velasco S et al. | β | 2019 | β |
| Induced pluripotent stem cells in disease modelling and drug discovery. | Rowe RG et al. | β | 2019 | β |
| Modeling Psychiatric Diseases with Induced Pluripotent Stem Cells. | van Hugte E et al. | β | 2019 | β |
| OLIG2 Drives Abnormal Neurodevelopmental Phenotypes in Human iPSC-Based Organoid and Chimeric Mouse Models of Down Syndrome. | Xu R et al. | β | 2019 | β |
| Organoids as hybrids: ethical implications for the exchange of human tissues. | Boers SN et al. | β | 2019 | β |
| Pluripotent Stem Cells for Brain Repair: Protocols and Preclinical Applications in Cortical and Hippocampal Pathologies. | Alia C et al. | β | 2019 | β |
| Specification of positional identity in forebrain organoids. | Cederquist GY et al. | β | 2019 | β |
| The critical importance of basic animal research for neuropsychiatric disorders. | Bale TL et al. | β | 2019 | β |
| The use of iPSC technology for modeling Autism Spectrum Disorders. | Russo FB et al. | β | 2019 | β |
| Using human stem cells as a model system to understand the neural mechanisms of alcohol use disorders: Current status and outlook. | Scarnati MS et al. | β | 2019 | β |
| Alpha6-Containing Nicotinic Acetylcholine Receptors Mediate Nicotine-Induced Structural Plasticity in Mouse and Human iPSC-Derived Dopaminergic Neurons. | Collo G et al. | β | 2018 | β |
| Brain Organoids: Expanding Our Understanding of Human Development and Disease. | Chuye LB et al. | β | 2018 | β |
| Connectome development and a novel extension to the neurodevelopmental model of schizophrenia. | Collin G et al. | β | 2018 | β |
| Development and disease in a dish: the epigenetics of neurodevelopmental disorders. | Lewis EM et al. | β | 2018 | β |
| Effects of 3D culturing conditions on the transcriptomic profile of stem-cell-derived neurons. | Tekin H et al. | β | 2018 | β |
| Engineering Brain Organoids to Probe Impaired Neurogenesis Induced by Cadmium. | Yin F et al. | β | 2018 | β |
| Engineering stem cell-derived 3D brain organoids in a perfusable organ-on-a-chip system. | Wang Y et al. | β | 2018 | β |
| Generation and assembly of human brain region-specific three-dimensional cultures. | Sloan SA et al. | β | 2018 | β |
| Genetics of Alcohol Use Disorder: A Role for Induced Pluripotent Stem Cells? | Prytkova I et al. | β | 2018 | β |
| Genomics in neurodevelopmental disorders: an avenue to personalized medicine. | TΔrlungeanu DC et al. | β | 2018 | β |
| Human brain organoid-on-a-chip to model prenatal nicotine exposure. | Wang Y et al. | β | 2018 | β |
| Human Models Are Needed for Studying Human Neurodevelopmental Disorders. | Zhao X et al. | β | 2018 | β |
| Human Neurospheroid Arrays for In Vitro Studies of Alzheimer's Disease. | Jorfi M et al. | β | 2018 | β |
| Human stem cell modeling in neurofibromatosis type 1 (NF1). | Wegscheid ML et al. | β | 2018 | β |
| <i>In vitro</i> models of molecular and nano-particle transport across the blood-brain barrier. | Hajal C et al. | β | 2018 | β |
| Modeling human diseases with induced pluripotent stem cells: from 2D to 3D and beyond. | Liu C et al. | β | 2018 | β |
| Modeling Neurological Diseases With Human Brain Organoids. | Wang H | β | 2018 | β |
| Modelling Alzheimer's disease: Insights from in vivo to in vitro three-dimensional culture platforms. | Ranjan VD et al. | β | 2018 | β |
| Organoids: An intermediate modeling platform in precision oncology. | Jin MZ et al. | β | 2018 | β |
| Organoids required! A new path to understanding human brain development and disease. | Arlotta P | β | 2018 | β |
| Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells (NPCs). | Williams M et al. | β | 2018 | β |
| Somatic mutations in neurons during aging and neurodegeneration. | Verheijen BM et al. | β | 2018 | β |
| Stem cell contributions to neurological disease modeling and personalized medicine. | Liang N et al. | β | 2018 | β |
| Studying and modulating schizophrenia-associated dysfunctions of oligodendrocytes with patient-specific cell systems. | Raabe FJ et al. | β | 2018 | β |
| Studying the Brain in a Dish: 3D Cell Culture Models of Human Brain Development and Disease. | Brown J et al. | β | 2018 | β |
| Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: an overview of induced pluripotent stem-cell-based disease models. | Taoufik E et al. | β | 2018 | β |
| The daunting polygenicity of mental illness: making a new map. | Hyman SE | β | 2018 | β |
| The ethics of experimenting with human brain tissue. | Farahany NA et al. | β | 2018 | β |
| Three-Dimensional Models of the Human Brain Development and Diseases. | Jorfi M et al. | β | 2018 | β |
| Tracing Early Neurodevelopment in Schizophrenia with Induced Pluripotent Stem Cells. | Ahmad R et al. | β | 2018 | β |
| Tunable anisotropic networks for 3-D oriented neural tissue models. | Canadas RF et al. | β | 2018 | β |
| Uncovering True Cellular Phenotypes: Using Induced Pluripotent Stem Cell-Derived Neurons to Study Early Insults in Neurodevelopmental Disorders. | Fink JJ et al. | β | 2018 | β |
| A hollow fiber system for simple generation of human brain organoids. | Zhu Y et al. | β | 2017 | β |
| Animal models for neuropsychiatric disorders: prospects for circuit intervention. | Kaiser T et al. | β | 2017 | β |
| Cell diversity and network dynamics in photosensitive human brain organoids. | Quadrato G et al. | β | 2017 | β |
| Developing HiPSC Derived Serum Free Embryoid Bodies for the Interrogation of 3-D Stem Cell Cultures Using Physiologically Relevant Assays. | Phillips AW et al. | β | 2017 | β |
| Disease Modeling in Stem Cell-Derived 3D Organoid Systems. | Dutta D et al. | β | 2017 | β |
| Fusion of Regionally Specified hPSC-Derived Organoids Models Human Brain Development and Interneuron Migration. | Xiang Y et al. | β | 2017 | β |
| Genetic and Molecular Approaches to Study Neuronal Migration in the Developing Cerebral Cortex. | Dudok JJ et al. | β | 2017 | β |
| In situ generation of human brain organoids on a micropillar array. | Zhu Y et al. | β | 2017 | β |
| Lab-grown mini-brains upgraded. | Yang L et al. | β | 2017 | β |
| Modeling Human Neurological and Neurodegenerative Diseases: From Induced Pluripotent Stem Cells to Neuronal Differentiation and Its Applications in Neurotrauma. | Bahmad H et al. | β | 2017 | β |
| Models for discovery of targeted therapy in genetic epileptic encephalopathies. | Maljevic S et al. | β | 2017 | β |
| Organoid and Organ-On-A-Chip Systems: New Paradigms for Modeling Neurological and Gastrointestinal Disease. | Akhtar AA et al. | β | 2017 | β |
| Probing impaired neurogenesis in human brain organoids exposed to alcohol. | Zhu Y et al. | β | 2017 | β |
| Self-Organized Cerebral Organoids with Human-Specific Features Predict Effective Drugs to Combat Zika Virus Infection. | Watanabe M et al. | β | 2017 | β |
| Speech and Language: Translating the Genome. | Deriziotis P et al. | β | 2017 | β |
| Stem cell models of Alzheimer's disease: progress and challenges. | Arber C et al. | β | 2017 | β |
| The use of brain organoids to investigate neural development and disease. | Di Lullo E et al. | β | 2017 | β |
| Tranylcypromine Causes Neurotoxicity and Represses BHC110/LSD1 in Human-Induced Pluripotent Stem Cell-Derived Cerebral Organoids Model. | Huang J et al. | β | 2017 | β |